Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Circ J Retrieve available abstracts of 55 articles: HTML format

Single Articles

March 2025
1. ENDO K, Tanaka M, Sato T, Inyaku M, et al
   High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level?- A 10-Year Cohort Study.
   Circ J. 2025 Mar 15. doi: 10.1253/circj.CJ-24-0770.
   PubMed     Abstract available
   
   
   
2. KOJIMA Y, Inoue K, Shiozaki M, Sasaki S, et al
   Accuracy of the 0/1-Hour Algorithm for Diagnosing Myocardial Infarction in Patients With Atrial Fibrillation.
   Circ J. 2025 Mar 1. doi: 10.1253/circj.CJ-24-0811.
   PubMed     Abstract available
   
   
   February 2025
3. HANAZAWA K, Shiomi H, Morimoto T, Ando K, et al
   Suspected Fatal Arrhythmic Events in Japanese Patients With Coronary Artery Disease?- From the CREDO-Kyoto PCI/CABG Registries Cohorts-2 and -3.
   Circ J. 2025;89:364-372.
   PubMed     Abstract available
   
   
   
4. FUKUI K, Koide M, Takamatsu K, Sugimoto H, et al
   Clinical Outcomes of Percutaneous Coronary Intervention Using Drug-Coated Balloons for De Novo Coronary Lesions With Eruptive Calcified Nodules as Detected by Optical Coherence Tomography.
   Circ J. 2025;89:303-311.
   PubMed     Abstract available
   
   
   
5. WATASE M, Shiraishi Y, Chubachi S, Tanabe N, et al
   Coronary Artery Calcification on Chest Computed Tomography as a Predictor of Cardiovascular Adverse Events in Patients With COVID-19?- A Multicenter Retrospective Study in Japan.
   Circ J. 2025;89:373-381.
   PubMed     Abstract available
   
   
   
6. ZHANG Y, Wu Z, Zheng Z, Wang S, et al
   Long-Term Outcomes in Patients With Chronic Total Occlusion and Left Ventricular Systolic Dysfunction?- A Single-Center Inverse Probability of Treatment Weighting Analysis.
   Circ J. 2025;89:312-322.
   PubMed     Abstract available
   
   
   
7. OMORI H, Kawase Y, Mizukami T, Tanigaki T, et al
   Diagnostic Performance of Artificial Intelligence-Based Angiography-Derived Non-Hyperemic Pressure Ratio Using Pressure Wire as Reference.
   Circ J. 2025;89:323-330.
   PubMed     Abstract available
   
   
   
8. HAN JK, Lee SD, Hwang D, Park SH, et al
   Renal Function-Stratified Comparison of Short- and Long-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention With Third-Generation Drug-Eluting Stents?- Post Hoc Analysis From the HOST-IDEA Randomized Clinical Trial
   Circ J. 2025;89:281-291.
   PubMed     Abstract available
   
   
   
9. HONG SJ, Kim BK
   Potent P2Y(12) Inhibitor Monotherapy for Acute Coronary Syndrome.
   Circ J. 2025;89:272-280.
   PubMed     Abstract available
   
   
   December 2024
10. AOKI-KAMIYA C, Katsuragi S, Shiina Y, Hasegawa J, et al
    Maternal Death Due to Pulmonary Arterial Hypertension?- A Nationwide Survey in Japan.
    Circ J. 2024;89:77-82.
    PubMed     Abstract available
    
    
    October 2024
11. KIRIGAYA J, Matsuzawa Y, Kosuge M, Abe T, et al
    High Detectability of Prehospital 12-Lead Electrocardiogram in Diagnosing Spasm-Induced Acute Coronary Syndrome.
    Circ J. 2024;88:1800-1808.
    PubMed     Abstract available
    
    
    
12. YAMAMOTO T, Sugizaki Y, Kawamori H, Toba T, et al
    Enhanced Plaque Stabilization Effects of Alirocumab?- Insights From Artificial Intelligence-Aided Optical Coherence Tomography Analysis of the Alirocumab for Thin-Cap Fibroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherenc
    Circ J. 2024;88:1809-1818.
    PubMed     Abstract available
    
    
    
13. YOSHIKAWA M, Honda A, Arashi H, Shibahashi E, et al
    Addition of Ezetimibe to Intensive Lipid-Lowering Therapy Is Associated With a Lower Incidence of Heart Failure in Patients With Acute Coronary Syndrome.
    Circ J. 2024;88:1819-1824.
    PubMed     Abstract available
    
    
    
14. SHIBA T, Aizawa K, Ho M, Ishii K, et al
    Regulatory Review of Robotic-Assisted Percutaneous Coronary Intervention in Japan.
    Circ J. 2024;88:1737-1744.
    PubMed     Abstract available
    
    
    
15. YAMAMOTO K, Yamamoto E, Morimoto T, Shiomi H, et al
    Long-Term Effects of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention in High-Risk Subgroups.
    Circ J. 2024;88:1778-1787.
    PubMed     Abstract available
    
    
    
16. NISHINO M, Egami Y, Nohara H, Kawanami S, et al
    Impact of 12-Month Angioscopic Thrombi and Yellow Plaque After Drug-Eluting Stent Implantation.
    Circ J. 2024;88:1758-1767.
    PubMed     Abstract available
    
    
    
17. KUNO T, Miyamoto Y, Akita K, Shoji S, et al
    Low-Dose Prasugrel vs. Standard-Dose Clopidogrel for Patients Undergoing Percutaneous Coronary Intervention.
    Circ J. 2024;88:1745-1753.
    PubMed     Abstract available
    
    
    
18. SUGIYAMA T, Kakuta T, Hoshino M, Hada M, et al
    Predictors of Optical Coherence Tomography-Defined Calcified Nodules in Patients With Acute Coronary Syndrome?- A Substudy From the TACTICS Registry.
    Circ J. 2024;88:1853-1861.
    PubMed     Abstract available
    
    
    
19. MURAI T, Hikita H, Yamaguchi M, Ito A, et al
    Basal Coronary Microvascular Resistance Predicting Death and Heart Failure in Patients Without Functional Coronary Stenosis.
    Circ J. 2024;88:1788-1797.
    PubMed     Abstract available
    
    
    
20. AKIYAMA T, Ikegami R, Kubota N, Takano T, et al
    Serum Apolipoprotein-A2 Levels Are a Strong Predictor of Future Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention.
    Circ J. 2024;88:1770-1777.
    PubMed     Abstract available
    
    
    
21. OKITA S, Saito Y, Yaginuma H, Asada K, et al
    Impact of the Stress Hyperglycemia Ratio on Heart Failure and Atherosclerotic Cardiovascular Events After Acute Myocardial Infarction.
    Circ J. 2024 Oct 22. doi: 10.1253/circj.CJ-24-0612.
    PubMed     Abstract available
    
    
    
22. HANADA K, Sasaki S, Kinjo T, Shikanai S, et al
    Incidence and Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy in Japanese Ischemic Heart Disease Patients.
    Circ J. 2024 Oct 11. doi: 10.1253/circj.CJ-24-0436.
    PubMed     Abstract available
    
    
    
23. ONUMA S, Takahashi J, Shiroto T, Godo S, et al
    Characteristics and In-Hospital Outcomes of Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries?- Insights From the Real-World JAMIR Database.
    Circ J. 2024 Oct 9. doi: 10.1253/circj.CJ-24-0422.
    PubMed     Abstract available
    
    
    
24. ARAI R, Murata N, Saito Y, Kojima K, et al
    Prognostic Survey of ECPELLA in Japanese Patients With Acute Myocardial Infarction and Cardiogenic Shock?- Findings From the Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD).
    Circ J. 2024 Oct 2. doi: 10.1253/circj.CJ-24-0522.
    PubMed     Abstract available
    
    
    September 2024
25. OKADA S, Sakai A, Ohnishi Y, Yasudo H, et al
    Necrotic Change of Tunica Media Plays a Key Role in the Development of Coronary Artery Lesions in Kawasaki Disease.
    Circ J. 2024;88:1709-1714.
    PubMed     Abstract available
    
    
    
26. KUROBE M, Baba K, Nunohiro T, Ishizaki M, et al
    Impact of Implementation of a Region-Wide Low-Density Lipoprotein Cholesterol Management Clinical Pathway for the Secondary Prevention of Acute Myocardial Infarction.
    Circ J. 2024 Sep 14. doi: 10.1253/circj.CJ-24-0338.
    PubMed     Abstract available
    
    
    
27. SAITO Y, Kobayashi Y, Tsujita K, Kuwahara K, et al
    Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction?- A Clinical Review.
    Circ J. 2024 Sep 13. doi: 10.1253/circj.CJ-24-0633.
    PubMed     Abstract available
    
    
    August 2024
28. KUBO K, Hirata A, Kadota A, Harada A, et al
    Risk Factors for Heart Failure and Coronary Artery Disease Mortality Based on the National Vital Statistics During a 25-Year Follow-up in Japan?- NIPPON DATA90.
    Circ J. 2024;88:1478-1487.
    PubMed     Abstract available
    
    
    
29. KOBAYASHI Y, Iwakawa H, Yamanaka T, Seki K, et al
    Myocardial Infarction as the Initial Presentation of Cardiac Papillary Fibroelastoma?- Detection of a Mottled Mass Using Intravascular Ultrasound.
    Circ J. 2024 Aug 8. doi: 10.1253/circj.CJ-24-0529.
    PubMed    
    
    
    July 2024
30. NINOMIYA R, Koeda Y, Nasu T, Ishida M, et al
    Effect of Patient's Symptom Interpretation on In-Hospital Mortality in Acute Coronary Syndrome.
    Circ J. 2024;88:1225-1234.
    PubMed     Abstract available
    
    
    
31. NOMA S, Kato K, Otsuka T, Nakao YM, et al
    Sex Differences in Cardiovascular Disease-Related Hospitalization and Mortality in Japan?- Analysis of Health Records From a Nationwide Claim-Based Database, the Japanese Registry of All Cardiac and Vascular Disease (JROAD).
    Circ J. 2024;88:1332-1342.
    PubMed     Abstract available
    
    
    
32. NITTA M, Nakano S, Kaneko M, Fushimi K, et al
    In-Hospital Mortality in Patients With Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation With Concomitant Use of Impella vs. Intra-Aortic Balloon Pump?- A Retrospective Cohort Study Using a Japanese Claims-Based Database.
    Circ J. 2024;88:1276-1285.
    PubMed     Abstract available
    
    
    
33. YOKOYAMA M, Iyama K, Honda T, Maekawa K, et al
    Attitude of Emergency Medical Technicians Toward Electrocardiogram?- Needs of Electrocardiogram Training Courses and Other Learning Opportunities.
    Circ J. 2024;88:1315-1321.
    PubMed     Abstract available
    
    
    June 2024
34. SAITO Y, Tateishi K, Kanda M, Shiko Y, et al
    Volume-Outcome Relationships for Intra-Aortic Balloon Pump in Acute Myocardial Infarction.
    Circ J. 2024 Jun 27. doi: 10.1253/circj.CJ-24-0286.
    PubMed     Abstract available
    
    
    
35. MATSUZAWA Y, Tsujita K
    Standing Together With the General Public Against Acute Myocardial Infarction?- Japan's Efforts and Future Perspectives.
    Circ J. 2024 Jun 26. doi: 10.1253/circj.CJ-24-0391.
    PubMed    
    
    
    
36. KONDO Y, Noda T, Takanashi Y, Sasaki S, et al
    Two-Year Outcomes of Primary Prophylactic Use of Defibrillators for Ischemic and Non-Ischemic Cardiomyopathy?- Propensity Score-Matched Analysis From the Nippon Storm Study.
    Circ J. 2024;88:1107-1114.
    PubMed     Abstract available
    
    
    
37. KAWAMURA T, Mizutani K, Yoshida A, Fujita K, et al
    Successful Case of Transcatheter Edge-to-Edge Mitral Valve Repair for Patient With Cardiogenic Shock Due to Acute Myocardial Infarction Caused by Stent Thrombosis.
    Circ J. 2024 Jun 15. doi: 10.1253/circj.CJ-24-0238.
    PubMed    
    
    
    May 2024
38. MURAMATSU T, Onuma Y, Serruys PW
    Bioresorbable Scaffolds?- A Ray of Hope in the Darkness.
    Circ J. 2024;88:873-875.
    PubMed    
    
    
    
39. NAKAMURA M, Suzuki N, Fujii K, Furuya J, et al
    The Absorb GT1 Bioresorbable Vascular Scaffold System?- 5-Year Post-Market Surveillance Study in Japan.
    Circ J. 2024;88:863-872.
    PubMed     Abstract available
    
    
    
40. NISHIURA N, Kubo S, Fujii C, Shima Y, et al
    Fifteen-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation.
    Circ J. 2024;88:938-943.
    PubMed     Abstract available
    
    
    
41. HE J, Bian X, Zhang R, Yuan S, et al
    Impact of Relative Improvement in Quantitative Flow Ratio on Clinical Outcomes After Percutaneous Coronary Intervention?- A Subanalysis of the PANDA III Trial.
    Circ J. 2024;88:921-930.
    PubMed     Abstract available
    
    
    
42. ANDO H, Collet C, Amano T
    Can Coronary Flow Reserve After Stenting Be a Useful Predictor of Target Vessel Failure?
    Circ J. 2024;88:860-862.
    PubMed    
    
    
    
43. TAKAGI R, Kubo T
    Clinical Value of Optical Coherence Tomography in Guiding Bifurcation Percutaneous Coronary Intervention.
    Circ J. 2024;88:970-971.
    PubMed    
    
    
    
44. NOHARA A
    The Worst Combination for Coronary Artery Disease Under Strong-Statin Therapy Is Chronic Kidney Disease and Diabetes?- Non-Lipid Residual Risk Assessment From the REAL-CAD Study.
    Circ J. 2024;88:1004-1006.
    PubMed    
    
    
    
45. AKASE H, Okamura T, Nagoshi R, Fujimura T, et al
    Risk Assessment of Side Branch Compromise After Coronary Bifurcation Stenting?- A Substudy of the 3D-OCT Bifurcation Registry.
    Circ J. 2024;88:959-969.
    PubMed     Abstract available
    
    
    
46. SUZUKI N, Yokoi T, Kimura T, Ikeda Y, et al
    Prediction of Slow-Flow Phenomenon After Stent Implantation Using Near-Infrared Spectroscopy in Patients With Acute and Chronic Coronary Syndrome.
    Circ J. 2024;88:972-979.
    PubMed     Abstract available
    
    
    
47. HIGUMA T, Akashi YJ, Fukumoto Y, Obara H, et al
    Residual Coronary Risk Factors Associated With Long-Term Clinical Outcomes in Patients With Coronary Artery Disease Treated With High- vs. Low-Dose Statin Therapy?- REAL-CAD Substudy.
    Circ J. 2024;88:995-1003.
    PubMed     Abstract available
    
    
    
48. OKADA K
    Role of Sex Difference in Modifiable Risk Factors After Acute Myocardial Infarction.
    Circ J. 2024 May 22. doi: 10.1253/circj.CJ-24-0289.
    PubMed    
    
    
    April 2024
49. HOSHI T, Sawano M, Kohsaka S, Ishii H, et al
    Impact of Sex Differences on Clinical Outcomes in Patients Following Primary Revascularization for Acute Myocardial Infarction?- Insights From the Japanese Nationwide Registry.
    Circ J. 2024 Apr 27. doi: 10.1253/circj.CJ-23-0966.
    PubMed     Abstract available
    
    
    
50. FUJIYOSHI A, Kohsaka S, Hata J, Hara M, et al
    JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease.
    Circ J. 2024;88:763-842.
    PubMed    
    
    
    
51. KWON HW, Song MK, Lee SY, Kim GB, et al
    Risk Factors for Coronary Artery Complications After Prosthetic Pulmonary Valve Implantation in Patients With Congenital Heart Disease.
    Circ J. 2024;88:652-662.
    PubMed     Abstract available
    
    
    
52. DATE A
    Comprehensive Cardiac Rehabilitation for Patients With Myocardial Infarction?- Impact on Prognosis in Patients With Low Exercise Capacity.
    Circ J. 2024 Apr 20. doi: 10.1253/circj.CJ-24-0245.
    PubMed    
    
    
    
53. HIRUMA T, Nakayama A, Sakamoto J, Hori K, et al
    Comprehensive Cardiac Rehabilitation Following Acute Myocardial Infarction Improves Clinical Outcomes Regardless of Exercise Capacity.
    Circ J. 2024 Apr 17. doi: 10.1253/circj.CJ-23-0668.
    PubMed     Abstract available
    
    
    
54. KIM CH, Lee SH, Kim HK, Kim MC, et al
    Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Non-ST-Elevation Myocardial Infarction.
    Circ J. 2024 Apr 11. doi: 10.1253/circj.CJ-24-0129.
    PubMed     Abstract available
    
    
    March 2024
55. SASAKI S, Kawamori H, Toba T, Takeshige R, et al
    Diagnostic Accuracy of Pre-Transcatheter Aortic Valve Replacement Nitroglycerin-Free Fractional Flow Reserve-Computed Tomography-Based Physiological Assessment in Patients With Severe Aortic Stenosis for Predicting Post-Transcatheter Aortic Valve Repl
    Circ J. 2024;88:501-509.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.